In current smokers with COPD, LABA plus LAMA is superior to LABA plus ICS, regardless of blood eosinophils. Data from the FLAME trial
Authors
Mathioudakis, A.Higham, A.
Bate, S.
Chatzimavridou-Grigoriadou, Victoria
Sivapalan, P.
Jensen, J. U.
Felton, T.
Vestbo, J.
Singh, D.
Affiliation
Christie Hospital NHS Foundation Trust, Manchester, United KingdomIssue Date
2024